| Name | dienogest |
|---|---|
| Synonyms |
DIENOGEST CAS NO.:65-9
BAY-86-5258 17a-Cyanomethyl-17-hydroxyestra-4, 9-dien-3-one STS 557 Endometrion Dienogest, Steroidal progesterone Dienogestrel //BP Dienogest (steroid) Visanne 2-((8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)acetonitrile [3H]-Dienogest Dienogest,Dienogestrel ,Dienogestril 3-(4-methoxyphenyl)-2-sulfanylidene-5,6,7,8-tetrahydro-1H-benzothiolo[2,3-d]pyrimidin-4-one STS557 Dinagest Dienogest, 10 mM in DMSO 17a-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile Dienogestril 17a-Cyanomethyl-17b-hydroxy-estra-4,9(10)-dien-3-one UNII-46M3EV8HHE STS 557;STS557;STS-557 Dienogest CRS 17a-Cyanomethyl-17-hydroxyestra-4,9-dien-3-one Dienogestrel 17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile 4, 9-ESTRADIENE-17α-CYANOMETHYL-17β-OL-3-ONE MJR-35 Dienogest for system suitability (Y0001782) Dienogest Impurity 17a-CyanoMethyl-17b-hydroxyestra-4, 9-dien-3-one ienoges BAY 8 (17α)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile (17a)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile (17R)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile Dinogest Dienogest (STS-557) BAY8 [14C]-Dienogest Contractive (oral) 19-Norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17α) Ene, with Dienogest for system suitability CRS 17a-CyanoMethyl-17b-hydroxyestra-4,9-dien-3-one 13C,2H3,15N]-Dienogest D6-Dienogest 17α-Cyanomethyl-17β-hydroxyestra-4,9-dien-3-one 17alpha-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile Dienogestrel Impurity Dinogestrel Dinogestrin |
| Description | Dienogest(STS-557) is a specific progesterone receptor agonist with potent oral endometrial activity and is used in the treatment of endometriosis. Target: progesterone receptor agonistDienogest is an orally active synthetic progesterone (or progestin). It is available for use as an oral contraceptive in combination with ethinylestradiol. It has antiandrogenic activity and as a result can improve androgenic symptoms. It is a non-ethinylated progestin which is structurally related to testosterone [1]. Complete sperm suppression was observed in rats sacrificed either 60 or 90 days after dienogest (DNG)+ testosterone undecanoate (TU) administration, for two injections at 45-day interval. The neutral α-glucosidase activity in these treated rats remained in the normal range. Germ cell loss due to apoptosis was frequently observed both after 60 or 90 days of combination treatment. Significant decline in serum gonadotropin and testosterone, both serum and intratesticular levels, were observed in the treated rats. Following stoppage of treatment (given at 45-day interval) after two (0 and 45 days) or three injections (0, 45 and 90 days), complete restoration of spermatogenesis was observed by 120 and 165 days, respectively [2].Clinical indications: Adenomyosis; EndometriosisFDA Approved Date: 1995 Toxicity: weight gain; increased blood pressure; breast tenderness and nausea |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 549.0±50.0 °C at 760 mmHg |
| Melting Point | 210-214ºC |
| Molecular Formula | C20H25NO2 |
| Molecular Weight | 311.418 |
| Flash Point | 285.8±30.1 °C |
| Exact Mass | 311.188538 |
| PSA | 61.09000 |
| LogP | 1.96 |
| Vapour Pressure | 0.0±3.3 mmHg at 25°C |
| Index of Refraction | 1.589 |
| Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H361 |
| Precautionary Statements | P280 |
| Hazard Codes | Xn |
| RIDADR | NONH for all modes of transport |
| Precursor 4 | |
|---|---|
| DownStream 4 | |